-
Thelma Therapeutics¡¯ Phase 3 IND for Covid-19 cure rejected in Korea 매일경제11:42Thelma Therapeutics Co., whose Kospi shares are suspended upon receiving disclaimer opinion, has been denied by the local drug authority to proceed with its
-
Louis Vuitton, Hermès enjoy bumper pandemic year as Koreans lavish on luxuries 매일경제11:24Luxury fashion houses Hermès, Chanel and Louis Vuitton enjoyed a bumper year in South Korea as rich Koreans bound at home amid pandemic went on a spending s
-
Kosdaq revisits 1,000 threshold for the first time in nearly 21 years 매일경제11:00South Korea’s secondary Kosdaq revisited 1,000 level for the first time since the IT bubble burst in 2000 on foreign buying in bio and battery stocks. Kosda
-
[Graphic News] S. Korea 3rd-largest chip materials market in 2020: report 코리아헤럴드10:01South Korea, home to chipmaking giants such as Samsung Electronics and SK hynix, was the world's third-largest market for semiconductor materials in 2020,
-
Posco projects 10-year high OP in Q1 on demand recovery, steel price hikes 매일경제09:48South Korea's leading steelmaker Posco projected its operating profit for the first quarter more than doubled from a year ago to top 1.5 trillion won ($1.3 b
-
[Achim Steiner] Myanmar's young demand their future 코리아헤럴드05:31Half of Myanmar’s population is under the age of 30, and many of these young people have benefited from their country’s fragile, imperfect democratic trans
-
[Lee Hyuk] ASEAN and Korea amid mounting US-China rivalry 코리아헤럴드05:31The bitter war of words at the US-China Foreign Ministers’ Meeting held in Alaska last March portended the rough waves of the new Cold War between the US an
-
[Editorial] Go all out for vaccines 코리아헤럴드05:30The use of AstraZeneca’s vaccine against COVID-19 resumed for the under-60s Monday, except for those aged 30 and below. South Korea suspended providing the